2-107988201-C-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_021815.5(SLC5A7):​c.46C>T​(p.Leu16Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00138 in 1,614,090 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L16I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00098 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 5 hom. )

Consequence

SLC5A7
NM_021815.5 missense

Scores

14
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 0.789
Variant links:
Genes affected
SLC5A7 (HGNC:14025): (solute carrier family 5 member 7) This gene encodes a sodium ion- and chloride ion-dependent high-affinity transporter that mediates choline uptake for acetylcholine synthesis in cholinergic neurons. The protein transports choline from the extracellular space into presynaptic terminals for synthesis into acetylcholine. Increased choline uptake results from increased density of this protein in synaptosomal plasma membranes in response to depolarization of cholinergic terminals. Dysfunction of cholinergic signaling has been implicated in various disorders including depression, attention-deficit disorder, and schizophrenia. An allelic variant of this gene is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.024518013).
BP6
Variant 2-107988201-C-T is Benign according to our data. Variant chr2-107988201-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 464174.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000985 (150/152296) while in subpopulation SAS AF= 0.0027 (13/4822). AF 95% confidence interval is 0.00159. There are 0 homozygotes in gnomad4. There are 74 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC5A7NM_021815.5 linkuse as main transcriptc.46C>T p.Leu16Phe missense_variant 2/9 ENST00000264047.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC5A7ENST00000264047.3 linkuse as main transcriptc.46C>T p.Leu16Phe missense_variant 2/91 NM_021815.5 P1
SLC5A7ENST00000409059.5 linkuse as main transcriptc.46C>T p.Leu16Phe missense_variant 2/91 P1

Frequencies

GnomAD3 genomes
AF:
0.000986
AC:
150
AN:
152178
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00140
Gnomad OTH
AF:
0.00334
GnomAD3 exomes
AF:
0.00175
AC:
440
AN:
251474
Hom.:
1
AF XY:
0.00197
AC XY:
268
AN XY:
135908
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00320
Gnomad FIN exome
AF:
0.00176
Gnomad NFE exome
AF:
0.00241
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00142
AC:
2071
AN:
1461794
Hom.:
5
Cov.:
30
AF XY:
0.00151
AC XY:
1099
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.000358
Gnomad4 AMR exome
AF:
0.000335
Gnomad4 ASJ exome
AF:
0.000918
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00299
Gnomad4 FIN exome
AF:
0.00195
Gnomad4 NFE exome
AF:
0.00139
Gnomad4 OTH exome
AF:
0.00146
GnomAD4 genome
AF:
0.000985
AC:
150
AN:
152296
Hom.:
0
Cov.:
33
AF XY:
0.000994
AC XY:
74
AN XY:
74458
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.00144
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00270
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00140
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00135
Hom.:
0
Bravo
AF:
0.000899
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00204
AC:
248
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00224
EpiControl
AF:
0.00207

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:2
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 07, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicMar 20, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2022- -
Likely benign, criteria provided, single submitterclinical testingGeneDxAug 27, 2024See Variant Classification Assertion Criteria. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 28, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Neuronopathy, distal hereditary motor, type 7A;C4310694:Congenital myasthenic syndrome 20 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
SLC5A7-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 14, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.60
D;D
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Uncertain
0.93
.;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.025
T;T
MetaSVM
Uncertain
0.43
D
MutationAssessor
Uncertain
2.8
M;M
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-2.6
D;D
REVEL
Uncertain
0.45
Sift
Uncertain
0.0060
D;D
Sift4G
Benign
0.074
T;T
Polyphen
0.34
B;B
Vest4
0.41
MVP
0.71
MPC
0.99
ClinPred
0.030
T
GERP RS
5.7
Varity_R
0.34
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143876748; hg19: chr2-108604657; COSMIC: COSV50895379; API